MI4 unveils first round of Seed Fund Grants
Interdisciplinary and multi-institutional projects aim to tackle infectious and immune threats to human health
The Centre for Outcomes Research and Evaluation’s third Annual Research Day was a success!
The May 14 event organized by the Centre for Outcomes Research and Evaluation (CORE) provided an opportunity for trainees from all eight RI-MUHC programs to share their work and discoveries.
Recognizing great ideas at the McGill Clinical Innovation Competition
Congratulations to two winning teams from the RI-MUHC: BetaSense and Antibiotic Sentinel!
Guidelines for managing anaphylaxis in children need an update
New study shows that pre-hospital treatment with epinephrine has the highest protective effect against uncontrolled allergic reaction
Dr. Donald Sheppard honoured at the McGill Alumni Association’s annual Honours and Awards banquet
The David Johnston Faculty & Staff Award recognizes his leadership in research efforts to tackle grand challenges in infections and immunity
Widespread off-label use of epilepsy medications could put some patients at risk
Despite limited proven efficacy, gabapentinoids are frequently prescribed to treat pain
Drug-Resistant TB: A Clear and Present Danger
In two articles posted this week to Forbes, Dr. Madhukar Pai outlines the great threat posed by drug-resistant tuberculosis (DR-TB), while also offering a glimmer of hope.
Research Day for the IDIGH Program at the RI-MUHC is organized for and by trainees ... but everyone profits!
Nine awards were given across three presentation categories at the Fourth Annual Research Day of the Infectious Diseases and Immunity in Global Health Program
RI-MUHC researcher to receive new funding from GlycoNet
Dr. Don Sheppard`s project in collaboration with The Hospital for Sick Children aims to improve the health of Canadians while generating positive economic outcomes
Talking open science with Dr. Nitika Pant Pai
Dr. Nitika Pant Pai answers questions about her work with ScienceOpen and how it can benefit researchers and, ultimately, patients